Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207

Jonathan E. Rosenberg, Susan Halabi, Ben L. Sanford, Andrew L. Himelstein, J. N. Atkins, R.J. Hohl, Frederick Millard, Dean F. Bajorin, Eric J. Small

Annals of Oncology · 2008 · 53 citations · 18 references

DOIFull text

Open access

Concepts

References

18